GMAB•benzinga•
Cowen & Co. Initiates Coverage On Genmab with Market Perform Rating, Announces Price Target of $38
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 2, 2022 by benzinga